Dallas, Texas, Aug. 28, 2020 (GLOBE NEWSWIRE) -- The “Global Transdermal Drug Delivery System Market Size 2020, By Test (Transdermal Patches, Transdermal Semisolids) Application (Pain Management, Hormonal Applications, Central Nervous System Disorders, Cardiovascular Diseases, Other Applications) Region and Forecast 2021 to 2028” study provides an elaborative view of historic, present and forecasted market estimates.
Request a pdf sample at https://www.adroitmarketresearch.com/contacts/request-sample/1595
Adroit Market Research report on global catheter stabilization devices market gives a holistic view of the market from 2018 to 2028, which includes factors such as market drivers, restraints, opportunities, and challenges. The market has been studied for historic years from 2018 to 2019, with the base year of estimation as 2020 and forecast from 2021 to 2028. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the market competition with company positioning based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global Catheter Stabilization Devices market have been studied in detail.
The global transdermal drug delivery system market is projected to reach USD 8,117 million by 2028, growing at a CAGR of 4.7%. Enhancing bioavailability via bypassing first pass metabolism, improving tolerability and dosing, minimizing pharmaco-kinetic peaks and troughs and increasing patient compliance in continuous delivery are some of the factors driving the growth of the global transdermal drug delivery system (TDDS) market.
Browse the full report with Table of Contents and List of Figures at https://www.adroitmarketresearch.com/industry-reports/transdermal-drug-delivery-system-market
Transdermal drug delivery systems offer several important advantages over more traditional approaches, including longer duration of action resulting in a reduction in dosing frequency, increased convenience to administer drugs which would otherwise require frequent dosing, improved bioavailability, more uniform plasma levels, reduced side effects and improved therapy due to maintenance of plasma levels up to the end of the dosing interval, flexibility of terminating the drug administration by simply removing the patch from the skin, improved patient compliance and comfort via non-invasive, painless and simple application. Moreover, itching, and local edema can be caused by the drug, the adhesive, or other excipients in the patch formulation may hinder the market growth.
Are you looking for a DISCOUNT? If yes, then get in touch with us at https://www.adroitmarketresearch.com/contacts/discount/1595
The global transdermal drug delivery system market is categorized based on type and application. By type, transdermal patch is set to grow at a highest pace due to increased bioavailability. Application wise, the pain management segment is projected to account for the largest market share owing to its raising application in cancer pain management.
In 2020, North America was the largest market for transdermal drug delivery system owing to rising prevalence of targeted diseases. Moreover, Asia Pacific is projected to grow at a highest pace during the forecast period. Key players of the global transdermal drug delivery system market include Hisamitsu Pharmaceutical, Novartis, Mylan, UCB, Boehringer Ingelheim, GlaxoSmithKline, Johnson & Johnson, Endo International, 3M Company and Purdue Pharma among others.
Direct purchase the report at https://www.adroitmarketresearch.com/researchreport/purchase/1595
Table of Contents
1. Introduction
2. Research Methodology
3. Market Outlook
4. Transdermal Drug Delivery System Market by Type, 2018-2028 (USD Million)
5. Transdermal Drug Delivery System Market by Application, 2018-2028 (USD Million)
6. Transdermal Drug Delivery System Market by Region 2018-2028 (USD Million)
7. Competitive Landscape
8. Company Profiles
9. Appendix
Access research repository of Upcoming Reports @ https://adroitmarketresearch.com/upcoming.html
About Us:
Adroit Market Research is a global business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.
Contact Us:
Ryan Johnson
Account Manager - Global
3131 McKinney Ave Ste 600
Dallas, TX 75204
Email ID: sales@adroitmarketresearch.com
Phone No.: +1 972-362 -8199
Connect with us: Facebook | Twitter | LinkedIn